Late last month, NASDAQ-listed cannabis operator Flora Growth, which once operated one of Colombia’s largest outdoor cultivation facilities, became the latest to exit the cannabis industry, rebranding as an AI-focused digital asset firm ZeroStack Corp.
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The London Stock Exchange-listed medical cannabis operator saw its stock drop by nearly 60% this week, resulting in a dramatic downturn in its market capitalisation, after announcing that it has been forced to weather numerous delays in funding.
Florida-based Flora Growth has announced the sale of its Colombian-related subsidiaries and assets to a private company for CAD$0.8 million.
